| Title | Liquid Biopsy Market Size, Share & Trends [2029] |
|---|
| URL | https://www.linkedin.com/pulse/liquid-biopsy-market-size-share-trends-2029-rachel-paul-hbgqf/ |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Liquid Biopsy Market, Liquid Biopsy Market Size, Liquid Biopsy Market Share, Liquid Biopsy Market Growth |
|---|
| Meta Description | Natera, Inc. (US), QIAGEN (Netherlands), Myriad Genetics, Inc. (US), Illumina, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland) |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| Liquid Biopsy Market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of 11.9% from 2024 to 2029. |
